Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Docetaxel
Sponsor: Zhejiang Cancer Hospital